Our story
Before
2025
Creation
Trained as a physician and a computer scientist (MD and PhD in Artificial Intelligence, Sorbonne University), Khai Minh Pham saw the same problem in medicine and AI: “Will this drug work?” was answered only after patients were treated and billions spent.
He developed Macro-Connectionism, an intelligence in which self-organizing agents produce emergent reasoning, and used it to simulate biology itself.
Whole-cell AI clones of patients’ cells: drugs tested before they reach the clinic, on mechanism rather than precedent.
2026
onward
Scale
Jay Srinivasan joins, after executive roles at Abbott, Roche, Danaher, QIAGEN and Kodak, and as President & CEO of Truvian Health through FDA approval of the TruVerus platform.
Reads for the Molecule Economy: asymmetric insights to decide which molecules move forward.
David Thomas
Aline “Ali” Bettancourt, PhD
Touria Diagne
Mike Varney, PhD
Ben M.W. Illigens, MD
Bhasker Shetty, PhD